Living Donor TransplantationHenkie P. Tan, Amadeo Marcos, Ron Shapiro Edited by leaders at one of the acclaimed transplant institutions in the United States, this reference covers all aspects of living donor solid organ and cellular transplantation in current clinical practice, including the kidney, liver, pancreas, lung, small bowel, islet, and hematopoietic stem cell transplantation. Detailed, engaging, and organ- |
Contents
1 | |
7 | |
Chapter 3 General Medical Evaluation of the Living Donor | 27 |
Specific Issues for LivingDonor Kidney Transplantation | 33 |
Chapter 5 Technical Aspects of LiveDonor Nephrectomy | 49 |
Chapter 6 Perioperative Donor Risk | 69 |
Chapter 7 LongTerm Risks of Living Donation | 77 |
Chapter 8 LongTerm Outcomes for the Donor | 87 |
Evaluation Technical Aspects and Donor and Recipient Outcomes | 245 |
Chapter 23 Living LobarLung Transplantation | 259 |
Specific Issues and DonorRecipient Evaluation | 269 |
Surgical Technique | 281 |
Clinical Outcomes | 297 |
Chapter 27 Collection Processing and Infusion of Adult Hematopoietic Stem Cells Bone Marrow and Peripheral Blood Stem Cells | 309 |
Chapter 28 Applications and Outcomes of Autologous and Allogeneic Hematopoietic StemCell Transplantation | 319 |
Chapter 29 UmbilicalCord BloodCell Transplantation | 329 |
Chapter 9 Donor and Recipient Outcomes After Laparoscopic LiveDonor Nephrectomy | 101 |
Highly Sensitized Recipients Positive Crossmatches and ABO Blood Group Incompatibility | 113 |
Chapter 11 Expanding LiveDonor Renal Transplantation Through Paired and Nondirected Donation | 125 |
Chapter 12 LivingDonor Renal Transplantation in HIV Positive Recipients | 137 |
Chapter 13 Pediatric LivingDonor Kidney Transplantation | 149 |
Specific Issues | 159 |
Chapter 15 Technical Aspects of LiveDonor Hepatectomy | 169 |
Chapter 16 Donor Outcomes | 185 |
Chapter 17 Recipient Outcomes After LivingDonor Liver Transplantation | 197 |
The Pittsburgh Experience with Alemtuzumab Preconditioning and Tacrolimus MonotherapyTwoYear Outcomes | 207 |
Chapter 19 Pediatric LivingDonor Liver Transplantation | 217 |
Chapter 20 LivingDonor Liver Transplantation for Hepatocellular Carcinoma | 227 |
Chapter 21 LivingDonor Pancreas Transplantation | 235 |
Chapter 30 Anesthesia for LivingDonor Transplantation | 341 |
Chapter 31 Management of Infections in LivingDonor Transplant Recipients | 363 |
Chapter 32 Pregnancy After LivingDonor Transplantation | 379 |
Chapter 33 Financial Impact of LivingDonor Organ Transplantation | 395 |
Chapter 34 Transplantation Tolerance | 405 |
The Case for a Regulated System of Kidney Sales | 417 |
The Case Against Organ Sales from Living Persons | 431 |
Chapter 37 Consent to Living Kidney Donation | 435 |
Chapter 38 Consent to Living PartialLiver Donation | 441 |
449 | |
Back cover | 463 |
Other editions - View all
Living Donor Organ Transplantation(Softcover Edition for Special Sale) Henkie P. Tan,Amadeo Marcos,Ron Shapiro No preview available - 2008 |
Common terms and phrases
addition adult allograft allow antibody artery associated cells Center clinical compared complications considered cord blood costs death deceased donor developed diabetes disease donation donor nephrectomy early effects et al evaluation experience factors failure follow-up function glucose graft hepatic higher hospital HSCT human hypertension immunosuppression important improved increased infection islet kidney donors kidney transplantation laparoscopic LDLT less levels limited liver transplantation living donor living-donor lobe long-term loss lung major mean months morbidity mortality occur operation organ outcomes pancreas patients pediatric performed Pittsburgh placed population positive postoperative potential pregnancy present prior procedure pulmonary received rejection remaining removed renal transplantation reported risk segment significant studies successful Surg surgery surgical T-cell Table technique testing therapy tion tolerance transplant recipients treatment United University vascular vein waiting